4-Iodo-3-nitrobenzamide
CAS: 160003-66-7
Ref. 3D-FI140420
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 500mg | A consultar |
Información del producto
- AntiPARP-2
- Benzamide, 4-iodo-3-nitro-
- Bsi 201
- Iniparib
- Ino2Ba
- Niba
- Sar240550
- Sml 0623
Iniparib is a cancer drug that belongs to the class of platinum-based chemotherapy drugs. It inhibits the activity of pro-apoptotic proteins and is used to treat ovarian cancer with low potency. Iniparib has been shown to inhibit the growth of breast cancer cells, as well as other types of cancers. The drug also has an inhibiting effect on metabolic disorders, such as obesity and diabetes, which may be linked to its homologous properties. Iniparib may be useful in treating certain cancers because it has minimal toxicity levels and a low potential for systemic side effects that are common with other chemotherapeutic agents.END>
Propiedades químicas
Consulta técnica sobre: 3D-FI140420 4-Iodo-3-nitrobenzamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
